Univentricular Heart

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2023-05-15
Clinical Trial Update: Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease [Phase 3]
Phase 3 trial evaluating PDE5 inhibitors in single-ventricle patients with pulmonary hypertension was withdrawn.